ArticleCurrent treatment options in gastroenterology2016
Treat to Target in Inflammatory Bowel Disease.
Article in Current treatment options in gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Radioimmune Imaging of αPharmaceutics · 2023Article
- Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021Article
- An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020Article
- Anti-inflammatory Activity of Mollugin on DSS-induced Colitis in Mice.Current medical science · 2020Article
- Inflammatory Bowel Disease On-Line Web-Based Guide to Health Professionals and Patients in Developing and African Nations.Japanese journal of gastroenterology and hepatology · 2020Article
- Predicting and preventing complications in children with inflammatory bowel disease.Translational pediatrics · 2019Review
- Web-based learning in inflammatory bowel diseases: General truths and current specifics.World journal of clinical cases · 2018Review
- Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease.Intestinal research · 2018Article
- Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring.Intestinal research · 2018Article
- Managing IBD Therapies in Pregnancy.Current treatment options in gastroenterology · 2017Review
- Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.Clinical pharmacology : advances and applications · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementWith the expanding armamentarium in IBD the current treatment targets can be reached. By optimally using our drugs we can avoid long-term complications in IBD. For this the therapeutic strategy has to be changed from a clinically driven approach to a target-driven strategy. Currently mucosal healing, normalization of biomarkers, histological healing, and healing on abdominal imaging are proposed targets. Correct phenotyping of the patient before initiation of therapy is mandatory. Once treatment is initiated a continuous re-evaluation with consequent adaptation of the treatment when goals are not (yet) reached is needed. Both escalation and de-escalation should be considered. Drug levels can be used as a guidance to reach these targets.
Indexed as
Identifiers
26864745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.